semaglutide 25 mg Weight Loss and Cardiovascular Events Risk Reduction Oral Wegovy approved for obesity
Description
Microdosing GLP-1 for Hashimoto's: explore the evidence, potential benefits, safety concerns, and NHS guidance on using GLP-1 receptor agonists for autoimmune thyroid disease and metabolic symptoms.
Beyond improving glycemic control, these therapies promote weight loss and lower blood pressure when used individually, and in an additive manner when used together
But their side effects often drive people to stop using them over the long term.
Curious what a healthcare provider has to say about what people considering starting a GLP-1 medication should know
